-
Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction.
Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1668-73. -
Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT, Avgidou K, Spencer K, Nix B, Nicolaides KH.
Am J Obstet Gynecol 2006;194:397-401. -
Cell-free DNA levels in pregnancies at risk of sickle-cell disease and significant ethnic variation.
Gerovassili A, Nicolaides KH, Thein SL, Rees DC.
Br J Haematol 2006;135:738-41. -
Fetal growth restriction and postnatal development.
Eleftheriades M, Creatsas G, Nicolaides K.
Ann N Y Acad Sci 2006;1092:319-30. -
Maternal cardiac function in fetal growth restriction.
Bamfo JE, Kametas NA, Turan O, Khaw A, Nicolaides KH.
BJOG 2006;113:784-91. -
Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH.
Prenat Diagn 2005;25:949-53. -
Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K, Crossley JA, Aitken DA, Nicolaides KH.
Prenat Diagn 2005;25:358-61. -
The role of uterine artery Doppler in predicting adverse pregnancy outcome.
Papageorghiou AT, Yu CK, Nicolaides KH.
Best Pract Res Clin Obstet Gynaecol 2004;18:383-96. -
First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY, Liao AW, Munim S, Spencer K, Nicolaides KH.
J Matern Fetal Neonatal Med 2004;15:176-80. -
Comparison of color Doppler uterine artery indices in a population at high risk for adverse outcome at 24 weeks' gestation.
Albaiges G, Missfelder-Lobos H, Parra M, Lees C, Cooper D, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;21:170-3. -
Second-trimester uterine artery Doppler screening in unselected populations: a review.
Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;12:78-88. -
Platelet changes and subsequent development of pre-eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening.
Missfelder-Lobos H, Teran E, Lees C, Albaiges G, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;19:443-8. -
Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia.
Parra MC, Lees C, Mann GE, Pearson JD, Nicolaides KH.
Am J Obstet Gynecol 2001;184:497-502. -
Repeatability of measurement of uterine artery pulsatility index using transvaginal color Doppler.
Papageorghiou AT, To MS, Yu CK, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:456-9. -
Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation.
Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:441-9. -
First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction.
Ong CY, Liao AW, Cacho AM, Spencer K, Nicolaides KH.
Obstet Gynecol 2001;98:608-11. -
Mass spectral analysis of asymmetric hemoglobin hybrids: demonstration of Hb FS alpha2gammabetaS) in sickle cell disease.
Ofori-Acquah SF, Green BN, Davies SC, Nicolaides KH, Serjeant GR, Layton DM.
Anal Biochem 2001;298:76-82. -
Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation.
Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:583-6. -
Individualized risk assessment for adverse pregnancy outcome by uterine artery Doppler at 23 weeks.
Lees C, Parra M, Missfelder-Lobos H, Morgans A, Fletcher O, Nicolaides KH.
Obstet Gynecol 2001;98:369-73. -
Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta hCG and PAPP-A at 10-14 weeks of gestation.
Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH.
Prenat Diagn 2000;20:411-6.